Synchronous non-small cell lung cancers

被引:38
作者
Pommier, RF
Vetto, JT
Lee, JT
Johnston, KM
机构
[1] Section of Surgical Oncology, Division of General Surgery, Oregon Health Sciences University, Portland, OR
[2] Department of Surgery, Section of Surgical Oncology, Oregon Health Sciences University, Portland, OR 97201
关键词
D O I
10.1016/S0002-9610(96)00019-0
中图分类号
R61 [外科手术学];
学科分类号
摘要
INTRODUCTION: The few series of synchronous lung cancers have included small cell and carcinoid tumors. We wished to determine the prognosis for patients with synchronous non-small cell lung cancer (NSCLC). METHODS: A database of 3034 lung cancer patients was reviewed for synchronous NSCLC. Survival was determined by Kaplan-Meier method and compared by log-rank analysis. RESULTS: There were 27 patients (0.8%). Fourteen were completely resected (CR) and had a 5-year survival rate of 45% The 5-year survival rate for patients whose highest stage tumor was stage I or II was 38%, versus 0% for patients whose highest tumor stage of III (P = 0.01). The 5-year survival rate far patients with two stage I tumors was 41% versus 0% for patients with 2 stage III tumors (P = 0.03). The 5-year survival rate for patients treated with wedge resections was similar to that for patients treated with lobectomies or pneumonectomy (L/P). CONCLUSIONS: We conclude that the prognosis for patients with synchronous NSCLC may not be dismal if both tumors are resectable and stage I or II. Wedge resections are an alternative for those who cannot tolerate L/P.
引用
收藏
页码:521 / 524
页数:4
相关论文
共 11 条
[1]   CARCINOMA IN-SITU AND EVALUATION OF EPITHELIAL CHANGES IN LARYNGOPHARYNGEAL BIOPSIES [J].
BAUER, WC ;
MCGAVRAN, MH .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1972, 221 (01) :72-&
[2]   SYNCHRONOUS PRIMARY LUNG CANCERS - PREVALENCE IN SURGICAL MATERIAL AND CLINICAL IMPLICATIONS [J].
CAREY, FA ;
DONNELLY, SC ;
WALKER, WS ;
CAMERON, EWJ ;
LAMB, D .
THORAX, 1993, 48 (04) :344-346
[3]  
DESCHAMPS C, 1990, J THORAC CARDIOV SUR, V99, P769
[4]  
FERGUSON MK, 1985, J THORAC CARDIOV SUR, V89, P378
[5]   SIGNIFICANCE OF CARCINOMA IN SITU AND DYSPLASIA IN ASSOCIATION WITH BLADDER-CANCER [J].
KAKIZOE, T ;
MATUMOTO, K ;
NISHIO, Y ;
OHTANI, M ;
KISHI, K .
JOURNAL OF UROLOGY, 1985, 133 (03) :395-398
[6]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[7]   PREOPERATIVE CHEMOTHERAPY FOR STAGE IIIA (N2) LUNG-CANCER - THE SLOAN-KETTERING EXPERIENCE WITH 136 PATIENTS [J].
MARTINI, N ;
KRIS, MG ;
FLEHINGER, BJ ;
GRALLA, RJ ;
BAINS, MS ;
BURT, ME ;
HEELAN, R ;
MCCORMACK, PM ;
PISTERS, KMW ;
RIGAS, JR ;
RUSCH, VW ;
GINSBERG, RJ .
ANNALS OF THORACIC SURGERY, 1993, 55 (06) :1365-1374
[8]  
MARTINI N, 1975, J THORAC CARDIOV SUR, V70, P606
[9]  
MOUNTAIN CF, 1986, CHEST, V89, pS225, DOI 10.1378/chest.89.4.225S
[10]   MULTIPLE PRIMARY LUNG CARCINOMAS - PROGNOSIS AND TREATMENT [J].
ROSENGART, TK ;
MARTINI, N ;
GHOSN, P ;
BURT, M .
ANNALS OF THORACIC SURGERY, 1991, 52 (04) :773-779